Evaluates cannabinoids for glioblastoma treatment, suggesting potential therapeutic benefits.
C and 8-oxo-dG contents. These results show that cannabinoids alone or in combination with the current standard glioblastoma chemotherapeutic, TMZ, inhibit the progression of GBM and could be used for its clinical treatment. The mechanism of cannabinoids' actions on glioblastoma cells is also proposed.
No takes yet. Share an insight, caveat, or question.
Barciszewska et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: